Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Ischemic stroke and hypoxic-ischemic encephalopathy are leading causes of disability.
• Current treatments are limited, highlighting the need for novel therapeutic strategies.
• Secondary neurodegeneration and impaired plasticity impact long-term recovery.

Purpose of the Study:

• To explore the dual role of C3a receptor (C3aR) signaling in ischemic brain injury.
• To discuss therapeutic opportunities for modulating C3aR activity in stroke and birth asphyxia.
• To review recent insights into C3aR's impact on brain recovery and neurodegeneration.

Main Methods:

• Literature review of studies on C3a receptor signaling in ischemic conditions.
• Analysis of C3aR's effects in both acute and chronic phases of brain ischemia.
• Focus on findings in adult ischemic stroke and immature ischemic brain models.

Main Results:

• C3a receptor signaling has detrimental effects in the acute phase of adult ischemic stroke.
• C3aR signaling promotes better outcomes in the post-acute/chronic phases and in the immature ischemic brain.
• Understanding these differential roles is key to therapeutic targeting.

Conclusions:

• C3aR signaling presents a complex but promising target for neuroprotection.
• Modulating C3aR activity could offer new therapeutic avenues for ischemic stroke and birth asphyxia.
• Further research into C3aR's precise mechanisms is warranted for clinical translation.